Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2007, p. 234-236, Vol. 45, No. 1
0095-1137/07/$08.00+0 doi:10.1128/JCM.01867-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Center for Research on Intracellular Bacteria, Institute of Microbiology,1 Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland2
Received 8 September 2006/ Accepted 12 October 2006
|
|
|---|
|
|
|---|
Chlamydia-like organisms grown using amoebal coculture (12, 13) and purified on sucrose barrier were used as antigens to immunize mice. Acanthamoeba castellanii (ATCC 30010) was used to grow P. acanthamoebae strain BN9 (ATCC VR-1476), P. acanthamoebae strain Hall's coccus, P. amoebophila strain UWE25 (ATCC PRA-7), S. negevensis (ATCC VR-1471), W. chondrophila (ATCC 1470), C. sequanensis (CRIB-18), and R. crassificans (CRIB-01). Hartmannella vermiformis strain BL was used to grow N. hartmannellae (ATCC 50802). Purified bacteria were injected intravenously to 6-week-old BALB/c mice (two mice per antigen). After four immunizations, blood was collected, and sera were obtained by centrifugation at 5,200 x g for 5 min at 4°C. Twofold-diluted sera were tested by immunofluorescence for antibody reactivity against purified antigens. Fluorescein isothiocyanate-coupled anti-mouse immunoglobulin antibody (Bio-Rad, Rheinach, Switzerland) was used as a secondary antibody. Phosphate-buffered saline-milk and uninfected axenic A. castellanii (ATCC 30010) were used as negative controls. The IgG/IgM Micro-IF test kit (ANILabsystems, Vantaa, Finland) was used to test the antibody reactivity of mice sera against Chlamydia trachomatis, Chlamydophila psitacci, and Chlamydophila pneumoniae antigens.
Mice responded adequately to injected antigens. Very high titers of 1/32,768 and 1/16,384 were obtained after immunization with W. chondrophila and P. acanthamoebae strain Hall's coccus, respectively. Similar results were obtained for each duplicate sera, with titers varying by less than one dilution. Sera elicited against any of all Chlamydia-like organisms tested did not exhibit cross-reactivity against amoeba. The serological cross-reactivity (SDI) between two bacteria, expressed as the number of twofold dilution steps separating homologous and heterologous titers, were calculated as described previously (9). Table 1 shows antibody titers and SDIs obtained from reciprocal cross-reactions of mouse antisera with different Chlamydia-like organisms, as determined by immunofluorescence. Significant cross-reactivity was observed between closely related species, for instance, between the P. amoebophila and P. acanthamoebae strains. In contrast, no or little cross-reactivity was detected between distantly related Chlamydia-like organisms. No cross-reactivity against C. pneumoniae, C. trachomatis, and C. psittaci was detected when we tested sera elicited with any Chlamydia-like organisms, except P. acanthamoebae strain Hall's coccus that reacted with C. pneumoniae (titer of 1/128). A tree inferred from SDIs was built by using the neighbor-joining option of the PHYLIP software (10). 16S rRNA sequences were used to infer another neighbor-joining tree (see Fig. 1A for the GenBank accession numbers), using Kimura-corrected p-distance and the complete deletion option of the MEGA software (18). Both SDI and 16S rRNA-based trees were rooted using W. chondrophila as an outgroup. The phyletic tree based on the SDI was congruent with the tree inferred from 16S rRNA encoding gene sequences (Fig. 1A). This suggests that cross-reactivity between members of the Chlamydiales order is proportional to the level of relatedness between each species, i.e., to the likeliness of common epitopes.
|
View this table: [in a new window] |
TABLE 1. Antibody titers and SDIs obtained from reciprocal cross-reactions of mouse antisera with different Chlamydia-like organisms, as determined by immunofluorescence
|
![]() View larger version (51K): [in a new window] |
FIG. 1. (A) Congruence of the phylogenetic tree based on the 16S rRNA encoding gene (left panel) and the phyletic tree based on the SDI (right panel). Both trees were built by using the neighbor-joining method and were outrooted with Waddlia chondrophila. The 16S rRNA sequences were downloaded from GenBank. The accession numbers are as follows: Waddlia chondrophila, AF042496; Rhabdochlamydia crassificans, AY928092; Simkania negevensis, U68460; Neochlamydia hartmannellae, AF177275; Protochlamydia amoebophila, BX908798; Parachlamydia acanthamoebae strain Hall's coccus, AF366365; and Parachlamydia acanthamoebae strain BN9, Y07556. (B) Western blot pattern of each Chlamydia-like organisms. Each serum elicited in mice (two sera raised against each bacteria) was tested against its autologous antigen. All sera were tested at a 1/64 dilution. Lanes: A and B, Parachlamydia acanthamoebae strain BN9; C and D, Parachlamydia acanthamoebae strain Hall's coccus; E and F, Protochlamydia amoebophila; G and H, Neochlamydia hartmannellae; I and J, Waddlia chondrophila; K and L, Simkania negevensis; M and N, Rhabdochlamydia crassificans. The molecular sizes reported on the left of the figure were determined by using the Kaleidoscope prestained marker (Bio-Rad).
|
P. amoebophila had immunogenic proteins of approximately 130, 70, 43, and 30 kDa. For P. acanthamoebae strain BN9, a protein of approximately 70 kDa exhibited the strongest immunogenicity. For N. hartmannellae, proteins of approximately 89, 70, 53, and 45 kDa exhibited the strongest immunogenicity, whereas proteins of W. chondrophila of about 70, 53, 45, and 30 kDa exhibited the highest immunogenicity. For S. negevensis, a protein of approximately 30 kDa exhibited the strongest immunogenicity, although having immunogenic proteins of approximately 130, 35, and 20 kDa. R. crassificans possess immunogenic proteins of 130, 89, 43, and 25 kDa (Fig. 1B). Earlier, Western blot has been used to confirm immunofluorescence results in two studies investigating the role of Chlamydia-like organisms in pneumonia (11, 25). The first study used as a positive control a rabbit serum elicited with P. acanthamoebae that exhibited a strong reactivity against proteins of about 70, 40, and 28 kDa (11). Here, we also identified a 70-kDa parachlamydial immunogenic protein. In the second study, a 64-kDa protein exhibited the strongest immunogenicity (4, 25).
Since serology was not discriminative at the species level for Parachlamydiaceae, previous serological studies suggesting a role of Parachlamydia as a new agent of pneumonia (2, 11, 21) should be interpreted as a hint for a role of either Parachlamydia or Parachlamydia-related species in respiratory tract infections. Conversely, serological studies aiming at defining the pathogenicity of Simkania spp. showed a high seroprevalence. The absence of cross-reactivity between Simkania spp., Parachlamydia spp. (Table 1), and all three Chlamydiaceae tested in our study support the idea that humans are frequently exposed to Simkania spp. or cross-reacting related species. Whether Simkania spp. cause respiratory tract diseases remains to be demonstrated since Kumar et al. (17) and Johnsen et al. (15) did not confirm early studies by Lieberman et al. (19, 20). Discrepant results might be due to some cross-reactivity of the enzyme-linked immunosorbent assay used by Lieberman et al. with Chlamydia-like organisms such as Rhabdochlamydia that exhibit common immunogenic proteins.
In conclusion, we have described the level of cross-reactivity and the molecular weight of immunogenic proteins of Chlamydia-like organisms. Understanding the pathogenic potential of Chlamydia-like organisms in humans and animals should be reconsidered using these findings.
This study was partially supported by Swiss National Science Foundation grant FN 3200130-105885.
Published ahead of print on 25 October 2006. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»